ArticleFrontiers in endocrinology2024

Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.

Jing Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.